Altisource Announces Second Quarter 2026 Financial Results

Altisource reported Q2 2026 Service revenue of $48.7M, up 19% y/y, but Adjusted EBITDA fell 18% y/y to $4.4M and the company posted a GAAP net loss attributable to shareholders of $0.6M (vs. a much larger 2025 tax-benefit-driven profit). Diluted EPS was $(0.05), while Adjusted diluted EPS was $0.17 (down $0.02 y/y). Management highlighted continued customer wins (Hubzu inventory +30% since Q1 2026) and expects to reach its Project 45 target of $45M run-rate Adjusted EBITDA by Q4 2028, alongside debt reduction via $2.0M debt repurchased at a 23.7% discount.

Analysis

The market is likely to overread the revenue inflection and underread the quality of that growth. The key tell is that top-line expansion is still being funded by a larger receivables build and a heavier SG&A structure, so this is not yet self-funding scale; it is a working-capital-intensive recovery. That matters because with leverage still elevated versus cash earnings, the equity is effectively a call option on management’s ability to keep winning business while converting sales into cash faster than the balance sheet bleeds.

The competitive read-through is that distressed-property and mortgage-services volume is improving, but not enough to create broad operating leverage across the niche. ASPS can win share from smaller, weaker vendors if foreclosure/origination activity stays firm, yet a more diversified customer base also implies lower concentration economics and more sales/implementation drag. In other words: diversification reduces single-client risk, but it can also cap margins if the new wins are fragmented and higher-touch.

Catalyst path is mostly 1-3 months, not days: the next print and commentary on cash conversion, not just pipeline, will determine whether this re-rates as a turnaround or a liquidity story. The contrarian bullish case is that if the new wins stabilize and debt service keeps coming down, 2027-2028 EBITDA could inflect sharply; the bearish case is that operating cash flow remains negative and the market starts valuing the story on covenant/financing risk instead of Project 45. A clean falsifier would be a quarter where receivables normalize and operating cash flow turns positive alongside margin stability; absent that, every revenue beat is just more balance-sheet strain.

Key Decisions for Investors

• Short ASPS on strength over the next 1-3 weeks; keep the position tactical and cover if the company posts two consecutive quarters of positive operating cash flow or adjusted EBITDA margin moves back above ~10%.
• Pair trade: short ASPS / long XHB or ITB for the next 1-3 months to isolate execution risk from the broader housing-cycle improvement. This keeps the trade focused on cash conversion and customer concentration rather than macro housing beta.
• If borrow is tight or liquidity is poor, use a downside options structure in ASPS rather than outright short common; prefer a 3-6 month put spread and only enter after any post-earnings bounce stalls.
• Set a watch item for the next quarter’s receivables growth versus service revenue growth: if receivables keep outpacing revenue, treat the equity as a liquidity-sensitive name and avoid longs until cash generation improves.